8 new PBS listings recommended

PBAC gives green light to drugs for diabetes, asthma, COPD

Fixed-dose combination products for type 2 diabetes, asthma and COPD are the winners in the latest round of recommendations for PBS listings. At its most recent meeting in November, the PBAC made the following recommendations relating to the listing of drugs on the PBS:

  1. Allow patients with persistent COPD symptoms, despite regular monotherapy with a long-acting muscarinic antagonist (LAMA) or long-acting beta-2 agonist (LABA), to move straight to fixed-dose combination inhalers such as tiotropium with olodaterol (Spiolto Respimat), aclidinium with